HippoFi
-
Biologics
HippoFi Welcomes Scott Bauccio As New Head Of Sales For PUR Biologics
IRVINE, CA., January 23, 2024 – OrthoSpineNews – HippoFi’s (OTCPK: ORHB) biotechnology business PUR Biologics, proudly announces Scott Bauccio as…
Read More » -
Biologics
HippoFi Ships International Orders And Expects Sales To Exceed $20 Million In The New Year
HippoFi’s wholly owned subsidiary, PUR Biologics breaks into the international market IRVINE, CA., December 11, 2023 / OrthoSpineNews / –…
Read More » -
Biologics
HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities
Expanding our reach in 2024, HippoFi and PUR Biologics are setting new standards in innovative spine care solutions. IRVINE CA.,…
Read More » -
Biologics
HippoFi to Announce Strategic Alliance with Orthopedic Leader
IRVINE, CA., September 1, 2023 / OrthoSpineNews / – HippoFi, Inc. (OTCPK: ORHB) – HippoFi, in association with its wholly…
Read More » -
Biologics
HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica
PUR Biologics, a HippoFi biotech company, launches PURmarrow360 with BPB Medica, aiming to improve US patient safety and clinical outcomes…
Read More » -
Biologics
HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device
IRVINE, CA., July 25, 2023 /OrthoSpineNews/ – HippoFi, Inc. (OTCPK:ORHB) a leading healthcare technology company and authority in spinal biologics,…
Read More » -
Biologics
HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market
IRVINE, CA., July 25, 2023 /OrthoSpineNews/ – HippoFi, Inc. (OTCPK:ORHB) – HippoFi, a healthcare technology and innovation firm focused on…
Read More » -
Biologics
HippoFi’s PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States
The nation’s largest system includes 1,298 healthcare facilities IRVINE, CA., June 28, 2023 / OrthoSpineNews / – HippoFi, Inc. (OTCPK:ORHB)…
Read More » -
Biologics
PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough™
PURbonedough™ positioned to capture its share of the forecasted total spine market expected to grow from 13.3 billon in 2023…
Read More » -
Biologics
PUR Biologics Expands Sales Network by 15% Adding 32 New Distributors
IRVINE, CA., April 27, 2023 /OrthoSpineNews/ – HippoFi, Inc. (OTCPK: ORHB), a leading healthcare innovator and technology company, is proud…
Read More » -
Biologics
Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.
BALTIMORE, MD., April 21, 2023 /OrthoSpineNews/ – Goldman Small Cap Research, a stock market research firm specializing in the small cap…
Read More »